EQS-News: SÜSS MicroTec SE: Dr. Goetz M. Bendele announces break until 31 December 2022 from his office as CEO of SÜSS MicroTec SE / Dr. Bernd Schulte takes over the Management Board position for this period
EQS-News: SÜSS MicroTec SE
/ Key word(s): Personnel
SÜSS MicroTec SE: Dr. Goetz M. Bendele announces break until 31 December 2022 from his office as CEO of SÜSS MicroTec SE / Dr. Bernd Schulte takes over the Management Board position for this period
14.10.2022 / 08:36 CET/CEST
The issuer is solely responsible for the content of this announcement.
Dr. Goetz M. Bendele announces break until 31 December 2022 from his office as CEO of SÜSS MicroTec SE / Dr. Bernd Schulte takes over the Management Board position for this period
Garching, Germany, October 14, 2022 – Today, the Supervisory Board of SÜSS MicroTec SE complied with the request of Dr. Goetz M. Bendele, Chief Executive Officer of SÜSS MicroTec SE, to temporarily step down as Member of the Management Board and Chief Executive Officer of the company for the period from 17 October 2022 to 31 December 2022. The reason for the temporary break is the serious illness of a family member. In doing so, Dr. Goetz M. Bendele is making use of Section 84 (3) of the German Stock Corporation Law (AktG). This statutory regulation, which went into effect in 2021 as part of the legislative procedure of the Second German Act on Equal Participation of Men and Women in Executive Positions in the Public and Private Sectors (FüPoG II), makes it possible for Members of the Management Board to temporarily step down from their position and completely detach themselves from the responsibilities associated with their mandate in the event that they become unable to execute their tasks.
Dr. David Dean, Chair of the Supervisory Board of SÜSS MicroTec SE, says, “We clearly wish to support Dr. Bendele during these difficult times and welcome the corresponding legal opportunities afforded by the German Stock Corporation Act. The Supervisory Board sincerely wishes him and his family all the best for the coming weeks and months.”
For the duration of absence, the Supervisory Board has appointed its member Dr. Bernd Schulte to the Management Board of SÜSS MicroTec SE, where he will also take over as its Chair. Dr. Bernd Schulte (60) worked for AIXTRON SE, a listed (MDax) provider of deposition equipment for the semiconductor industry, uninterruptedly from 1993 to 2021. In 2002, he was appointed to the Management Board of AIXTRON and was most recently responsible for the areas of Research and Development, Production, Procurement, Investor Relations, and Communications. After 19 years as member of the Management Board, the physicist left the company in 2021 at his own request after his contract expired. Through his work on the Supervisory Board of SÜSS MicroTec SE, Dr. Bernd Schulte is very familiar with the company.
“On behalf of the Supervisory Board, I would like to thank Dr. Bernd Schulte for his readiness to temporarily take over the office of Chief Executive Officer on short notice. Thanks to his long tenure in the Management Board of AIXTRON SE, he possesses profound industry knowledge and capital market experience, which will enable him to adequately fulfill the demands of this important office for the next two and a half months,” says Dr. David Dean. Following his temporary role in the Management Board, Dr. Bernd Schulte will return to the Supervisory Board of SÜSS MicroTec SE.
“I am grateful to the Supervisory Board of SÜSS MicroTec SE for the trust they have placed in me. Together with my colleagues in the Management Board and the entire workforce, we will continue the development of the company and the course we have set in the weeks to come,” says Dr. Bernd Schulte. “I wish Dr. Bendele and his family a great deal of strength and all the best.”
Dr. Goetz M. Bendele comments, “I would like to thank the Supervisory Board for approving my request to take time off due to this particular situation my family is in. I am convinced that SUSS MicroTec will continue to develop positively in the coming weeks. SUSS MicroTec is now a stable company on a sustainable growth path. Its management will be in excellent hands with Dr. Schulte.”
About SUSS MicroTec
SUSS MicroTec is a leading manufacturer of system and process solutions for micropatterning in the semiconductor industry and related markets. In close collaboration with research institutes and industry partners, SUSS MicroTec drives the development of next-generation technologies such as 3D integration and nanoimprint lithography as well as key processes for MEMS and LED production. With its global infrastructure for applications and service, SUSS MicroTec supports more than 8,000 installed systems worldwide. The headquarters of SUSS MicroTec is in Garching, near Munich, Germany. SUSS MicroTec SE’s shares are traded in the Prime Standard segment of the Deutsche Börse (ISIN DE000A10K0235). Additional information can be found at www.suss.com.
Legal Disclaimer
Some of the statements in this press release may be similar in character to forecasts or can be interpreted as such. All information and assessments are based on extremely conscientious research; however, publication is made with no guarantee of their accuracy. All liability is excluded. The statements made above do not constitute an invitation to buy or sell securities. All rights reserved.
Contact:
SÜSS MicroTec SE
Sven Koepsel
Investor Relations & Corporate Communications
Schleissheimer Strasse 90
85748 Garching, Germany
Tel.: +49 89 32007-151
Email: [email protected]
14.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
Language: |
English |
Company: |
SÜSS MicroTec SE |
|
Schleissheimer Strasse 90 |
|
85748 Garching |
|
Germany |
Phone: |
+49 (0)89 32007-161 |
Fax: |
+49 (0)89 4444 33420 |
E-mail: |
[email protected] |
Internet: |
www.suss.com |
ISIN: |
DE000A1K0235 |
WKN: |
A1K023 |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
1463655 |
|
End of News |
EQS News Service |
1463655 14.10.2022 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
166,52 |
203,93 |
213,80 |
252,11 |
263,44 |
299,14 |
304,26 |
EBITDA1,2 |
17,98 |
15,72 |
-5,19 |
28,20 |
29,60 |
41,90 |
34,65 |
EBITDA-Marge3 |
10,80 |
7,71 |
-2,43 |
11,19 |
11,24 |
14,01 |
|
EBIT1,4 |
13,90 |
10,87 |
-13,76 |
20,44 |
22,55 |
32,81 |
27,79 |
EBIT-Marge5 |
8,35 |
5,33 |
-6,44 |
8,11 |
8,56 |
10,97 |
9,13 |
Jahresüberschuss1 |
6,71 |
4,78 |
-16,26 |
12,36 |
16,02 |
24,52 |
4,70 |
Netto-Marge6 |
4,03 |
2,34 |
-7,61 |
4,90 |
6,08 |
8,20 |
1,55 |
Cashflow1,7 |
9,38 |
1,92 |
-30,80 |
55,16 |
24,33 |
23,94 |
3,79 |
Ergebnis je Aktie8 |
0,35 |
0,25 |
-0,85 |
0,65 |
0,84 |
1,28 |
0,25 |
Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,16 |
0,20 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Baker Tilly
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Süss MicroTec |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
A1K023 |
49,200 |
Kaufen |
940,48 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
25,89 |
26,35 |
0,97 |
75,23 |
KBV |
KCV |
KUV |
EV/EBITDA |
5,44 |
248,35 |
3,09 |
26,32 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
0,20 |
0,20 |
0,41 |
03.06.2025 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
08.05.2025 |
07.08.2025 |
07.11.2024 |
27.03.2025 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
-15,11% |
-6,63% |
77,62% |
93,32% |
|
|